MedPath

Comparison of prophylactic effect versus therapeutic effect of amiodarone in patients undergoing heart surgery at risk of atrial fibrillatio

Phase 3
Conditions
Atrial fibrillation.
Unspecified atrial fibrillation
I48.91
Registration Number
IRCT20120215009014N392
Lead Sponsor
Hamedan University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
All
Target Recruitment
200
Inclusion Criteria

Age: 18 to 65 years old
Candidate for elective cardiac surgery
Having a preoperative sinus rhythm

Exclusion Criteria

Use of antihypertensive drugs other than beta-blockers or ACE inhibitors
Thyroid, renal, pulmonary, hepatic disorders
Asthma
Bradycardia
Heart failure
Atrioventricular block
Sensitivity to amiodarone

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Incidence of atrial fibrillation. Timepoint: 24 hours after surgery. Method of measurement: Using a monitor machine.
Secondary Outcome Measures
NameTimeMethod
Incidence of side effects (such as hypotension and bradycardia). Timepoint: 24 hours after surgery. Method of measurement: using a monitor machine.
© Copyright 2025. All Rights Reserved by MedPath